UK biotech sees boost in biotech fundraising so far this year; ChemoCentryx kills plans for stock offer
→ BIA and Informa Pharma Intelligence reported Friday that the UK biotech industry saw $2.05 billion in new fundraising in the first 8 months of this year — more than all of last year. That figure adds venture rounds with IPOs and follow-ons.
→ ChemoCentryx $CCXI is cancelling plans for a new offering to raise cash. The Mountain View, CA-based biotech says that “the company believes that culmination of terms representing the best interests of its stockholders is not to be achieved at the current time.”